Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 03, 2017
WIRB-Copernicus Group announced that it has acquired Patient Genesis' ConsentNow eConsent technology.
read more
Wednesday, March 24, 2021
Windtree is extending its collaboration with the University of Milan-Bicocca for the discovery and development of new SERCA2a compounds for the potential treatment of chronic and acute human heart failure.
read more
WindMIL Therapeutics have entered an agreement to expand WindMIL’s clinical manufacturing capacity.
read more
Thursday, December 19, 2019
WindMIL has entered into a research collaboration with Bristol-Myers Squibb to evaluate MILs in combination with Opdivo in patients with locally advanced unresectable or metastatic NSCLC.
read more
Tuesday, February 26, 2019
Wilmington PharmaTech is planning to hire up to 139 new employees and invest $18 million in a new state-of-the-science research and manufacturing facility.
read more
Willow Biosciences Inc., (“Willow”) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity optimization development program for
manufacturing a large volume anti-infective Active Pharmaceutical ...
read more
Albany Molecular Research, Inc. (NASDAQ: AMRI), a leading global contract research and manufacturing organization, today announced the appointment of William S. Marth to its Board of Directors. Mr. Marth has extensive experience in leading ...
read more
Whitehouse Labs has expanded impurity testing capacity in its Lebanon, NJ, facility with the addition of an Agilent 7900 ICP-MS (inductively coupled plasma mass spectrophotometer) system.
read more
Whitehouse Laboratories has expanded its drug delivery device testing capabilities to encompass the full series of ISO 80369 standard test procedures.
read more
Wednesday, December 14, 2016
Whitehouse Laboratories, a division of AMRI, announced the addition of Disinfectant Efficacy testing capability to its Microbiology Laboratory. Clients will now have the opportunity to test their disinfectants for effectiveness based on AOAC and USP ...
read more
Wednesday, December 16, 2015
AMRI has acquired all the outstanding equity interests of Whitehouse Laboratories, a provider of testing services that includes chemical and material analysis, method development and validation and quality control verification services to the ...
read more
Friday, November 04, 2022
Wheeler Bio and CRB announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).
read more
Thursday, October 05, 2023
Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices (CGMP) facility inside the Ziggurat...
read more
Thursday, December 01, 2022
Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian-expressed protein therapeutics, announced it has been granted a license to ATUM’s proprietary Leap-In Transposase...
read more
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round.
read more